Komori
Presentation materials for financial results9221FULUHASHI EPO CORPORATIONInformation and Communications, Services and Others

FY2025 Financial Results Presentation Materials

For FY2025, net sales, operating income and net income all reached record highs. For FY2026, net sales and operating income are expected to reach new record highs, while ordinary income and net income are expected to decline. The Company is also proceeding with the construction of a new plant, organizational changes and expanded shareholder returns.

Worth reading
71In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
938
¥ million
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFiscal year ending March 202513 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥9,383 million+7.2%
Operating profit¥1,152 million+10.9%
Ordinary income¥1,432 million+15.0%
Net income¥1,033 million+292.5%
Gross Profit Margin45.8 %
Operating profit margin12.3 %
Results for the three months of the current quarterセグメント別に四半期単独の売上高・営業利益をグラフで表示。連結全体の四半期単独実績はNot disclosed
Full-year earnings forecast
Net Sales
¥10,322 million
Gross profit
¥4,757 million
Operating profit
¥1,303 million
Ordinary income
¥1,335 million
Profit attributable to owners of the parent
¥905 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Biomaterials+¥566 million
Resource Circulation+¥33 million
Other+¥29 million
売上原価・販管費等△476百万円
New initiatives
  • 名古屋工場の新設・2025年10月稼働予定
  • 16ヶ所以上の工場新設計画
  • 経営戦略本部・事業開発部門・サステナビリティ推進部門の設置
  • Transition to a Company with an Audit and Supervisory Committee
  • 株主優待制度の検討開始
Key KPIsA metric the company considers important as a management benchmark.
  • ROE19.5 %
  • PBR1.8 times
    Year on year against the same period last year2024年3月期2.6倍から低下
  • PER10.1 times
    Year on year against the same period last year2024年3月期48.8倍から低下
  • Consolidated payout ratio31.9 %
    Year on year against the same period last year2024年3月期30.0%台から増加
  • 木質バイオマス取扱量目標100 万t/年
Unit price and quantity metricsThese figures show sales broken down by price and volume.
木材チップの原料調達量・製造販売量の増加、原料調達単価・販売単価の改定を記載。具体的な数量・単価はNot disclosed
Segment results
Biomaterials Business
Net Sales
¥6,848 million+9.1%
Profit
¥1,090 million+21.7%
Resource-Circulation Business
Net Sales
¥1,591 million+2.0%
Profit
¥72 million-9.6%
Other Businesses
Net Sales
¥1,305 million+6.6%
Profit
¥-2 million
Medium-term management plan targets
Net Sales
¥15,000 million
Target fiscal yearFiscal year ending March 2028
Operating profit
¥3,000 million
Target fiscal yearFiscal year ending March 2028
Operating profit margin
20 %
Target fiscal yearFiscal year ending March 2028
ROE
Over 15%
Target fiscal yearFiscal year ending March 2028
Establishment of a new factory16ヶ所以上
Financial targets
ROE
TargetOver 15%
Actual results19.5%
Cost of shareholders’ equity6～8%
Number of stores and locations
Number at period-end工場21ヶ所
Number of store openings and closures during the period愛知第八工場（一宮）1ヶ所稼働。16ヶ所以上の新設を予定し、名古屋工場1ヶ所が稼働予定、10ヶ所を計画中
Number of employees
Number of Employees443 人連結、2025年3月末
Capital expenditures
¥2,296 million投資キャッシュ・フローにおける有形固定資産の取得による支出
Annual Dividend
Fiscal year ending March 2025
¥28 per share
Fiscal year ending March 2026 forecast
¥30 per share
Payout ratio
31.9 %
Target将来的な連結配当性向35%程度、連結配当性向30%目途
Acquisition of treasury shares
Share repurchases disclosed as implemented. The amount, number of shares and period of the repurchase authorization are Not disclosed
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredFiscal year ending March 2025
Net Sales¥9,383 million (YoY +7.2%)
Operating profit¥1,152 million (YoY +10.9%)
Ordinary income¥1,432 million (YoY +15.0%)
Net income¥1,033 million (YoY +292.5%)
Gross Profit Margin45.8 %
Operating profit margin12.3 %
Results for the three months of the current quarterセグメント別に四半期単独の売上高・営業利益をグラフで表示。連結全体の四半期単独実績はNot disclosed
Full-year earnings forecastNet Sales ¥10,322 million / Gross profit ¥4,757 million / Operating profit ¥1,303 million / Ordinary income ¥1,335 million / Profit attributable to owners of the parent ¥905 million
Segment resultsBiomaterials Business Net Sales ¥6,848 million (YoY +9.1%) / Profit ¥1,090 million (YoY +21.7%) / Resource-Circulation Business Net Sales ¥1,591 million (YoY +2.0%) / Profit ¥72 million (YoY -9.6%) / Other Businesses Net Sales ¥1,305 million (YoY +6.6%) / Profit ¥-2 million
Breakdown of Factors Affecting the ChangeBiomaterials +¥566 million / Resource Circulation +¥33 million / Other +¥29 million / 売上原価・販管費等 △476百万円
Key KPIsIndicator name ROE / Value 19.5 % / Year on year against the same period last year Not disclosed, Indicator name PBR / Value 1.8 times / Year on year against the same period last year 2024年3月期2.6倍から低下, Indicator name PER / Value 10.1 times / Year on year against the same period last year 2024年3月期48.8倍から低下, Indicator name Consolidated payout ratio / Value 31.9 % / Year on year against the same period last year 2024年3月期30.0%台から増加, Indicator name 木質バイオマス取扱量目標 / Value 100 万t/年 / Year on year against the same period last year Not disclosed
Unit price and quantity metrics木材チップの原料調達量・製造販売量の増加、原料調達単価・販売単価の改定を記載。具体的な数量・単価はNot disclosed
Number of stores and locationsNumber at period-end 工場21ヶ所 / Number of store openings and closures during the period 愛知第八工場（一宮）1ヶ所稼働。16ヶ所以上の新設を予定し、名古屋工場1ヶ所が稼働予定、10ヶ所を計画中
Number of employeesNumber of Employees 443 人（連結、2025年3月末） / Changes during the period and hiring plan Not disclosed
Medium-term management plan targetsNet Sales ¥15,000 million / Operating profit ¥3,000 million / Operating profit margin 20 % / ROE Over 15% / Establishment of a new factory 16ヶ所以上
Financial targetsROE Target Over 15% / Actual results 19.5% / Cost of shareholders’ equity 6～8%
Annual DividendFiscal year ending March 2025 ¥28 per share / Fiscal year ending March 2026 forecast ¥30 per share
Payout ratio31.9 %
Acquisition of treasury sharesShare repurchases disclosed as implemented. The amount, number of shares and period of the repurchase authorization are Not disclosed
Capital expenditures2,296 百万円（投資キャッシュ・フローにおける有形固定資産の取得による支出）
New initiatives名古屋工場の新設・2025年10月稼働予定, 16ヶ所以上の工場新設計画, 経営戦略本部・事業開発部門・サステナビリティ推進部門の設置, Transition to a Company with an Audit and Supervisory Committee, 株主優待制度の検討開始
Items this document does not state (8)
Selling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

2025年3月期は、バイオマテリアル事業を中心とした取扱量・販売数量の増加、原料調達単価・販売単価の改定、各工場の順調な稼働、生産性向上が増収・増益に寄与した。一方、人件費、輸送コスト、地代家賃、減価償却費の増加が利益を押し下げた。純利益の大幅増加については、前年同期に投資有価証券評価損98百万円と債務保証損失引当金繰入額514百万円を計上した反動が示されている。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FY2025 Financial Results Presentation Materials | FULUHASHI EPO CORPORATION (9221) timely disclosure | Komori